Search results for "Cannabinol"

showing 10 items of 21 documents

Effects of tetrahydrocannabinol on glucose uptake in the rat brain

2017

Δ9-Tetrahydrocannabinol (THC) is the psychoactive component of the plant Cannabis sativa and acts as a partial agonist at cannabinoid type 1 and type 2 receptors in the brain. The goal of this study was to assess the effect of THC on the cerebral glucose uptake in the rat brain. 21 male Sprague Dawley rats (12-13 w) were examined and received five different doses of THC ranging from 0.01 to 1 mg/kg. For data acquisition a Focus 120 small animal PET scanner was used and 24.1-28.0 MBq of [18F]-fluoro-2-deoxy-d-glucose were injected. The data were acquired for 70 min and arterial blood samples were collected throughout the scan. THC, THC-OH and THC-COOH were determined at 55 min p.i. Nine volu…

Male0301 basic medicineCannabinoid receptormedicine.medical_treatmentGlucose uptakeStimulationPharmacologyPartial agonistRats Sprague-Dawley03 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicineFluorodeoxyglucose F18Tandem Mass Spectrometrymental disordersmedicineAnimalsDronabinolTetrahydrocannabinolCannabinoid Receptor AgonistsPharmacologyBrain MappingPsychotropic DrugsDose-Response Relationship DrugChemistryorganic chemicalsBrainGlucose030104 developmental biologyPositron-Emission TomographyCerebellar cortexArterial bloodCannabinoidRadiopharmaceuticals030217 neurology & neurosurgeryChromatography Liquidmedicine.drugNeuropharmacology
researchProduct

Understanding Cannabinoid Psychoactivity with Mouse Genetic Models

2007

Marijuana and its main psychotropic ingredient Δ9-tetrahydrocannabinol (THC) exert a plethora of psychoactive effects through the activation of the neuronal cannabinoid receptor type 1 (CB1), which is expressed by different neuronal subpopulations in the central nervous system. The exact neuroanatomical substrates underlying each effect of THC are, however, not known. We tested locomotor, hypothermic, analgesic, and cataleptic effects of THC in conditional knockout mouse lines, which lack the expression of CB1 in different neuronal subpopulations, including principal brain neurons, GABAergic neurons (those that release γ aminobutyric acid), cortical glutamatergic neurons, and neurons expres…

MaleMESH: Body TemperatureCannabinoid receptormedicine.medical_treatmentGene ExpressionMESH: Receptor Cannabinoid CB1NeocortexMESH: gamma-Aminobutyric AcidMESH: CatalepsyPharmacologyHippocampusMESH: Mice KnockoutMESH: Corpus StriatumBody TemperatureMESH: Autonomic Nervous SystemMESH: NeocortexMice0302 clinical medicineReceptor Cannabinoid CB1MESH: Behavior AnimalCannabinoid receptor type 1MESH: AnimalsMESH: Gene SilencingDronabinolMESH: NociceptorsBiology (General)gamma-Aminobutyric AcidMice Knockout0303 health sciencesBehavior Animalmusculoskeletal neural and ocular physiologyGeneral NeuroscienceMESH: Pain ThresholdNociceptorsMESH: Glutamic AcidMESH: InterneuronsMESH: Motor Activity3. Good healthGABAergicMESH: TetrahydrocannabinolGeneral Agricultural and Biological SciencesResearch Articlemedicine.drugPain ThresholdMESH: Gene ExpressionMESH: Psychotropic DrugsQH301-705.5Glutamic AcidMotor ActivityBiologyAutonomic Nervous SystemGeneral Biochemistry Genetics and Molecular Biologygamma-Aminobutyric acid03 medical and health sciencesGlutamatergicDopamine receptor D1InterneuronsCannabinoid Receptor Modulatorsmental disorders[SDV.BBM] Life Sciences [q-bio]/Biochemistry Molecular BiologymedicineAnimalsGenetic Predisposition to Disease[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular BiologyGene SilencingTetrahydrocannabinolMESH: MiceAnesthesiology and Pain Management030304 developmental biologyPharmacologyCatalepsyPsychotropic DrugsModels GeneticGeneral Immunology and MicrobiologyCannabinoidsIllicit Drugsorganic chemicalsMESH: MaleCorpus StriatumPrimerDisease Models Animalnervous systemCannabinoidNervous System Diseases030217 neurology & neurosurgeryNeurosciencePLoS Biology
researchProduct

The endocannabinoid system: emotion, learning and addiction

2008

The identification of the cannabinoid receptor type 1 (CB1 receptor) was the milestone discovery in the elucidation of the behavioural and emotional responses induced by the Cannabis sativa constituent Delta(9)-tetrahydrocannabinol. The subsequent years have established the existence of the endocannabinoid system. The early view relating this system to emotional responses is reflected by the fact that N-arachidonoyl ethanolamine, the pioneer endocannabinoid, was named anandamide after the Sanskrit word 'ananda', meaning 'bliss'. However, the emotional responses to cannabinoids are not always pleasant and delightful. Rather, anxiety and panic may also occur after activation of CB1 receptors.…

PharmacologyCannabinoid receptorAddictionmedia_common.quotation_subjectmedicine.medical_treatmentMedicine (miscellaneous)AnandamideEndocannabinoid systemPsychiatry and Mental healthchemistry.chemical_compoundnervous systemchemistryCannabinoid receptor type 1medicinelipids (amino acids peptides and proteins)CannabinoidAversive StimulusPsychologyTetrahydrocannabinolNeurosciencemedia_commonmedicine.drugAddiction Biology
researchProduct

Cannabis consumption and the risk of psychosis

2017

Summary Objectives: Cannabis is the most widely used illicit drug globally and its use has been linked to an increased risk for psychotic disorders. An association between cannabis consumption and psychotic symptoms was consistently reported by several studies. This case-control study aimed to widen the current findings about the impact of cannabis exposure on the risk of psychosis, by investigating the pattern of cannabis consumption in a sample of first-episode of psychosis (FEP) patients compared to healthy controls. Material and methods: 68 individuals who presented for the first time to mental health services of Palermo (Italy) with an ICD-10 diagnosis of psychotic disorders and 74 hea…

Settore M-PSI/08 - Psicologia ClinicaSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.cannabis schizophrenia psychosis tetrahydrocannabinol drug and schizophreniaSettore MED/25 - Psichiatria
researchProduct

Detectability of cannabinoids in the serum samples of cannabis users: Indicators of recent cannabis use? A follow‐up study

2021

Forensic toxicologists are frequently required to predict the time of last cannabis consumption. Several studies suggested the utility of minor cannabinoids as indicators of recent cannabis use. Because several factors influence blood cannabinoid concentrations, the interpretation of serum cannabinoid concentrations remains challenging. To assess the informative value of serum cannabinoid levels in cannabis users (in total N = 117 patients, including 56 patients who stated an exact time of last cannabis use within 24 h before blood sampling), the detectability of cannabinoids, namely delta-9-tetrahydrocannabinol (delta-9-THC), 11-hydroxy-delta-9-THC, 11-nor-9-carboxy-delta-9-THC, cannabichr…

Time FactorsCannabigerolmedicine.medical_treatmentPharmaceutical SciencePhysiologyTetrahydrocannabivarin01 natural sciencesAnalytical Chemistry03 medical and health scienceschemistry.chemical_compoundCannabichromene0302 clinical medicineTandem Mass SpectrometrymedicineHumansEnvironmental Chemistry030216 legal & forensic medicineSpectroscopybiologyCannabinoidsbusiness.industry010401 analytical chemistrybiology.organism_classification0104 chemical sciencesSubstance Abuse DetectionchemistryTetrahydrocannabinolic acidCannabinolMarijuana UseCannabinoidSample collectionCannabisbusinessChromatography LiquidFollow-Up Studiesmedicine.drugDrug Testing and Analysis
researchProduct

IN-UTERO Δ9-TETRAHYDROCANNABINOL EXPOSURE IMPINGES ON BRAIN EXECUTIVE PROCESSES TOWARDS EMOTIONAL, COGNITIVE IMPAIRMENT, AND ALCOHOL VULNERABILITY IN…

2022

cannabidiolprenatalexecutive functionalcohol vulnerabilitySettore BIO/09 - Fisiologiaemotional and cognitive impairmentΔ9-TETRAHYDROCANNABINOL
researchProduct

Analysis of Contact Traces of Cannabis by In-Tube Solid-Phase Microextraction Coupled to Nanoliquid Chromatography

2018

Because of its inherent qualities, in-tube solid-phase microextraction (IT-SPME) coupled on-line to nanoliquid chromatography (nanoLC) can be a very powerful tool to address the new challenges of analytical laboratories such as the analysis of traces of complex samples. This is the case of the detection of contact traces of drugs, especially cannabis. The main difficulties encountered in the analysis of traces of cannabis plants on surfaces are the low amount of sample available (typically &lt

cannabisTHCmedicine.medical_treatmentSample (material)nanoliquid chromatography (nanoLC)CannabinolPharmaceutical Sciencecontact trace analysisSolid-phase microextraction01 natural sciencesArticleGas Chromatography-Mass SpectrometryAnalytical Chemistrylcsh:QD241-441Matrix (chemical analysis)03 medical and health scienceschemistry.chemical_compound0302 clinical medicinelcsh:Organic chemistryDrug DiscoverymedicineCannabidiolNanotechnology030216 legal & forensic medicineDronabinolPhysical and Theoretical ChemistrySolid Phase MicroextractionChromatographybiologyChemistryCannabinoidsPlant Extracts010401 analytical chemistryOrganic ChemistryExtraction (chemistry)biology.organism_classification0104 chemical sciencesChemistry (miscellaneous)CannabinolMolecular MedicineCannabinoidCannabisCannabidiolmedicine.drugin-tube solid-phase microextraction (IT-SPME)Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry
researchProduct

Cannabis Influences the Putative Cytokines-Related Pathway of Epilepsy among Egyptian Epileptic Patients

2019

The study aims to investigate: (1) the prevalence of cannabis among epileptic patients seen at Mansoura University Hospital, (2) serum levels and gene expression of cytokines in epilepsy patients and the controls. and (3) the possibility that cannabis use affects the cytokine levels in epilepsy patients, triggering its future use in treatment. We recruited 440 epilepsy patients and 200 controls matched for age, gender, and ethnicity. Of the epileptic patients, 37.5% demonstrated lifetime cannabis use with a mean duration of 15 &plusmn

cannabismedicine.medical_specialtypurified cannabidiol (cbd)inflammatory cytokinesmedicine.medical_treatmenttreatment-resistant epilepsyArticlelcsh:RC321-571Proinflammatory cytokine03 medical and health sciencesEpilepsy0302 clinical medicineInternal medicinemedicineanticonvulsant drugslcsh:Neurosciences. Biological psychiatry. Neuropsychiatryseizures030304 developmental biology0303 health sciencesbiologybusiness.industryGeneral NeuroscienceInterleukintetrahydrocannabinol (thc)Cannabis useUniversity hospitalbiology.organism_classificationmedicine.diseaseCytokineepilepsyTumor necrosis factor alphaCannabisbusiness030217 neurology & neurosurgeryBrain Sciences
researchProduct

Stability of 11-Nor-Δ9-carboxy-tetrahydrocannabinol Glucuronide in Plasma and Urine Assessed by Liquid Chromatography-Tandem Mass Spectrometry

2002

Abstract Background: Unconjugated 11-nor-Δ9-carboxy-tetrahydrocannabinol (THCCOOH) in blood and urine has been proposed as a valuable marker, but the glucuronide (THCCOOglu) is present in considerably higher concentrations than the parent drug. Acyl glucuronides have been shown to be potentially reactive conjugates, which may affect the in vitro metabolite pattern. Methods: Extraction procedures and a liquid chromatography-tandem mass spectrometry assay were developed and validated to investigate the stability of THCCOOglu in urine and plasma. Plasma and urine samples with added THCCOOglu were stored at −20, 4, 20, and 40 °C up to 10 days. Results: The glucuronide was stable at −20 °C in bo…

chemistry.chemical_compoundChromatographyMolar concentrationChemistryLiquid chromatography–mass spectrometryMetaboliteBiochemistry (medical)Clinical BiochemistryBlood plasmaCannabinolUrineGlucuronideMass spectrometryClinical Chemistry
researchProduct

Stability of Cannabinoids in Hair Samples Exposed to Sunlight

2000

It has been well recognized that hashish and marihuana lose potency during storage because of a decrease in the content of tetrahydrocannabinol (THC), which is the major psychoactive constituent of cannabis (1). The effect of oxygen on stored plant and resin materials or solutions of pure cannabinoids seems much less significant than that of higher temperatures (≥37 °C) or light (2)(3)(4)(5)(6)(7). A few data are available on the stability of THC and major metabolites in blood (8)(9)(10)(11). However, the stability of cannabinoids in the hair shaft has not been addressed, although scalp hair represents one of the most exposed parts of the body. Therefore, a study was performed to elucidate …

medicine.medical_treatmentClinical BiochemistryCannabinolAnalytical chemistryHashishSpecimen HandlingMatrix (chemical analysis)chemistry.chemical_compoundmedicineCannabidiolHumansDronabinolTetrahydrocannabinolDichloromethaneChromatographybiologyCannabinoidsBiochemistry (medical)biology.organism_classificationSubstance Abuse DetectionchemistrySunlightCannabinolCannabinoidCannabisCannabidiolHairmedicine.drugClinical Chemistry
researchProduct